On July 24, Tenet Healthcare surged 15.57% in after-hours trading, trading at approximately $233.00/share, with turnover of $4.44 million. The sharp rally followed the company's second-quarter earnings release before market open.

Market consensus had projected Q2 revenue of $5.43 billion, representing a 5.22% year-over-year increase, with adjusted EPS expected at $4.23, implying 47.29% year-over-year growth. The after-hours surge suggests the company likely delivered results well above these estimates, consistent with its recent track record of earnings beats. In the prior quarter, Tenet reported adjusted EPS of $4.82, significantly exceeding the $4.18 consensus estimate, while posting revenue of $5.368 billion and a net profit margin of 13.08%.

Tenet had guided full-year adjusted EPS in the range of $16.38 to $18.68, above the FactSet consensus of $17.22 at the time. Despite headwinds from the enhanced premium tax credit expiration expected to weigh approximately $250 million on adjusted EBITDA, strong cost efficiency and ambulatory care growth have continued to support profitability.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)